About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Safety of Pregnancy in BRCA Mutated Breast Cancer Patients

Safety of Pregnancy in BRCA Mutated Breast Cancer Patients

NCT03673306·81 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Jules Bordet Institute

Age

18–40

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of invasive breast cancer between January 2000 and December 2020;
Breast cancer diagnosis at the age of ≤ 40 years;
Known presence of germline BRCA mutation.

You may not be if

Known BRCA mutation with no diagnosis of invasive breast cancer;
Diagnosis of ovarian cancer or other malignancies with no history of invasive breast cancer;
Diagnosis of hereditary or familiar invasive breast cancer without BRCA mutation or with BRCA genes not tested;
Diagnosis of invasive breast cancer with germline BRCA variants of unknown significance.

The record

StatusCompleted

PhaseNo phase

Taking part4,732

StartedJan 2017

UpdatedDec 13, 2024

Conditions

Where81

Yale University
New Haven, Connecticut, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Michigan State University
Lansing, Michigan, United States